EVgo Hits Adjusted EBITDA Breakeven in Q4, Yet Profitability Path Remains Fraught

What happened

EVgo announced Q4 2025 results, achieving adjusted EBITDA breakeven for the quarter and positive adjusted EBITDA for the full year, while expanding its fast-charging footprint and outlining a higher deployment pace for 2026. This milestone follows repeated guidance resets noted in the DeepValue report, where management had previously revised 2025 EBITDA expectations from a positive midpoint to a negative range of -$15M to -$8M. The report highlights EVgo's structural loss-making nature, with Q3-25 Adjusted EBITDA at -$5.0M and ongoing risks from execution, policy changes, and potential equity dilution. Despite the Q4 improvement, the company's reliance on DOE loan facilities and partner agreements like GM/Pilot introduces covenant and competitive pressures that could undermine sustained profitability. Investors should scrutinize whether this breakeven is a one-time achievement or indicative of durable operational leverage as EV adoption faces headwinds.

Implication

The Q4 EBITDA breakeven reduces near-term cash burn concerns and aligns with EVgo's goal of approaching profitability, potentially supporting sentiment. However, it fails to address the core issue highlighted in the DeepValue report: the need for sustained quarterly revenue above $100M with breakeven-level Adjusted EBITDA and no equity issuance to justify a rating upgrade. Investors must monitor subsequent quarters for consistency, as historical guidance volatility and negative free cash flow persist, suggesting the company remains vulnerable to funding shortfalls. The higher 2026 deployment pace could strain capital resources, increasing the likelihood of dilution if DOE loan draws are constrained or covenant compliance weakens. Therefore, while operational momentum is improving, the investment case remains speculative, and entry should await clearer evidence of scalable profitability or a lower price to offset risks.

Thesis delta

The news partially addresses the profitability milestone sought in the DeepValue thesis, but it does not fulfill the stricter condition of two consecutive quarters with ≥$100M revenue and ≥0% Adjusted EBITDA without equity issuance. This shifts the thesis slightly toward monitoring for sustainability, yet the fundamental risks of dilution and execution remain unaltered, keeping the 'WAIT' rating intact until more robust evidence emerges.